UBP Investment Advisors’s Exact Sciences EXAS Stock Holding History

UBP Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,000	Closed	-$400K	–	120
2021 Q1	$400K	Hold	3,000	–	–	0.16%	89
2020 Q4	$397K	Buy	3,000 +1,000	+50%	+$121K	0.2%	51
2020 Q3	$306K	Sell	2,000 -1,000	-33%	-$86.4K	0.24%	45
2020 Q2	$261K	Buy	+3,000	New	+$240K	0.21%	46
2020 Q1	–	Sell	-3,500	Closed	-$324K	–	55
2019 Q4	$324K	Buy	3,500 +800	+30%	+$70.3K	0.25%	42
2019 Q3	$244K	Buy	2,700 +100	+4%	+$11.4K	0.2%	47
2019 Q2	$307K	Sell	2,600 -700	-21%	-$70.5K	0.28%	42
2019 Q1	$286K	Buy	+3,300	New	+$281K	0.27%	43
2018 Q4	–	Sell	-2,900	Closed	-$229K	–	48
2018 Q3	$229K	Buy	+2,900	New	+$189K	0.22%	54

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UBP Investment Advisors's EXAS Position: Q2 2021 in Review

UBP Investment Advisors sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 3,000 shares — an estimated $400K sold.

UBP Investment Advisors first reported a position in EXAS in Q3 2018 and held it in 9 quarters. The position peaked at $400K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

UBP Investment Advisors reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
UBP Investment Advisors sold 3,000 Exact Sciences shares in Q2 2021, an estimated $400K.
UBP Investment Advisors first reported a position in Exact Sciences in Q3 2018 and held it in 9 quarters.
UBP Investment Advisors's Exact Sciences position peaked at $400K in Q1 2021.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on UBP Investment Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.